Studies have also demonstrated that IL-6 stimulates the proliferation of small intestinal organoids through a STAT3-mediated signaling pathway42, which is relevant in head and neck cancer as dysregulated STAT3 signaling in HNSCC contributes to malignant behaviors, including enhanced growth, survival, and resistance to therapies43. The gene discussed is IL6; the disease is head and neck cancer.